Compass Therapeutics, Inc. (CMPX)
0.993
+0.01
(+0.98%)
USD |
NASDAQ |
Oct 09, 16:00
0.9912
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Free Cash Flow (Quarterly) : -14.91M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.91M |
| March 31, 2026 | -17.35M |
| December 31, 2025 | -13.25M |
| September 30, 2025 | -10.86M |
| June 30, 2025 | -11.83M |
| March 31, 2025 | -13.23M |
| December 31, 2024 | -9.162M |
| September 30, 2024 | -11.10M |
| June 30, 2024 | -10.75M |
| March 31, 2024 | -13.89M |
| December 31, 2023 | -12.36M |
| September 30, 2023 | -5.932M |
| June 30, 2023 | -10.12M |
| March 31, 2023 | -12.23M |
| December 31, 2022 | -10.70M |
| Date | Value |
|---|---|
| September 30, 2022 | -10.97M |
| June 30, 2022 | -4.537M |
| March 31, 2022 | -8.136M |
| December 31, 2021 | -5.442M |
| September 30, 2021 | -3.824M |
| June 30, 2021 | -6.553M |
| March 31, 2021 | -5.733M |
| December 31, 2020 | -6.656M |
| September 30, 2020 | -7.176M |
| June 30, 2020 | -5.304M |
| March 31, 2020 | -7.773M |
| December 31, 2019 | -5.776M |
| September 30, 2019 | -6.731M |
| June 30, 2019 | -8.904M |
| March 31, 2019 | -10.80M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | -125.17M |
| Capricor Therapeutics, Inc. | -37.39M |
| Ardelyx, Inc. | -6.412M |
| Biomea Fusion, Inc. | -10.03M |
| ARS Pharmaceuticals, Inc. | -60.93M |